Show simple item record

The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study

dc.contributor.authorBinswanger, Ingrid A.
dc.contributor.authorNguyen, Anh P.
dc.contributor.authorMorenoff, Jeffrey D.
dc.contributor.authorXu, Stanley
dc.contributor.authorHarding, David J.
dc.date.accessioned2020-12-02T14:36:26Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-12-02T14:36:26Z
dc.date.issued2020-12
dc.identifier.citationBinswanger, Ingrid A.; Nguyen, Anh P.; Morenoff, Jeffrey D.; Xu, Stanley; Harding, David J. (2020). "The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study." Addiction 115(12): 2329-2338.
dc.identifier.issn0965-2140
dc.identifier.issn1360-0443
dc.identifier.urihttps://hdl.handle.net/2027.42/163543
dc.description.abstractBackground and AimsDespite the high prevalence of substance use among people in the US criminal justice system, little is known about the incidence of overdose mortality by use patterns, drug convictions and supervision setting. We examined the associations between these characteristics and overdose mortality.DesignRetrospective cohort study.Setting and participantsIndividuals sentenced to prison, jail, probation or jail plus probation for a felony conviction in Michigan, USA from 2003 to 2006.MeasurementsUsing the National Death Index, we assessed overdose mortality to December 2012. We calculated overdose mortality rates by pre‐sentence opioid use, drug convictions and supervision setting. Multivariable analyses were conducted using competing risks regression with time‐varying covariates.FindingsAmong 140 266 individuals followed over a mean of 7.84 years [standard deviation (SD) = 1.52], 14.9% of the 1131 deaths were due to overdose (102.8 per 100 000 person‐years). Over the follow‐up, more than half of overdose deaths occurred in the community (57.7%), nearly a third (28.8%) on probation and 12.8% on parole. The adjusted risk of overdose death was lower on probation [hazard ratio (HR) = 0.71, 95% confidence interval (CI) = 0.60, 0.85] than in the community without probation or parole (HR = 1.00) but not significantly different on parole (HR = 1.13, 95% CI = 0.87, 1.47). Pre‐sentence daily opioid use (HR = 3.54, 95% CI = 3.24, 3.87) was associated with an increased risk. Drug possession (HR = 1.11, 95% CI = 0.93, 1.31) and delivery convictions (HR = 0.92, 95% CI = 0.77, 1.09) were not significantly associated with overdose mortality.ConclusionsBased on the absolute or relative risk, parole, probation and community settings are appropriate settings for enhanced overdose prevention interventions. Ensuring that individuals with pre‐sentence opioid use have access to harm reduction and drug treatment services may help to prevent overdose among people involved with the criminal justice system.
dc.publisherUS Department of Justice, Office of Justice Programs, Bureau of Justice Statistics
dc.publisherWiley Periodicals, Inc.
dc.subject.otherprisons
dc.subject.othermortality
dc.subject.otherepidemiology
dc.subject.otheropioids
dc.subject.otherdrug overdose
dc.subject.otherCohort studies
dc.titleThe association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelPsychiatry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163543/3/add15077.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163543/2/add15077-sup-0001-Supplementary_Appendix.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163543/1/add15077_am.pdfen_US
dc.identifier.doi10.1111/add.15077
dc.identifier.sourceAddiction
dc.identifier.citedreferenceHuxley‐Reicher Z., Maldjian L., Winkelstein E., Siegler A., Paone D., Tuazon E. et al. Witnessed overdoses and naloxone use among visitors to Rikers Island jails trained in overdose rescue. Addict Behav 2018; 86: 73 – 78.
dc.identifier.citedreferenceNunn A., Zaller N., Dickman S., Trimbur C., Nijhawan A., Rich J. D. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 2009; 105: 83 – 88.
dc.identifier.citedreferencePre‐Sentence Investigation and Report Policy Directive (06.01.140). Michigan Department of Corrections; 2012.
dc.identifier.citedreferenceZeng Z. Jail Inmates in 2017. Washington, DC: US Department of Justice, Bureau of Justice Statistics; 2019.
dc.identifier.citedreferenceProsecuting Attorneys Coordinating Council and Prosecuting Attorneys Association of Michigan. Electronic Warrant Manual. Lansing, MI: Prosecuting Attorneys Coordinating Council; 2010.
dc.identifier.citedreferenceMichigan Judicial Institute. State of Michigan Sentencing Guidelines Manual. Lansing, MI: Michigan Judicial Institute; 2013.
dc.identifier.citedreferenceBinswanger I. A., Stern M. F., Yamashita T. E., Mueller S. R., Baggett T. P., Blatchford P. J. Clinical risk factors for death after release from prison in Washington state: a nested case–control study. Addiction 2016; 111: 499 – 510.
dc.identifier.citedreferenceBinswanger I. A., Morenoff J. D., Chilcote C. A., Harding D. J. Ascertainment of vital status among people with criminal justice involvement using Department of Corrections Records, the US National Death Index, and social security master death files. Am J Epidemiol 2017; 185: 982 – 985.
dc.identifier.citedreferenceNational Center for Health Statistics. National Death Index User’s Guide. Hyattsville. MD: National Center for Health Statistics; 2013.
dc.identifier.citedreferenceCenters for Disease Control and Prevention (CDC). Wide‐ranging Online Data for Epidemiologic Research (CDC WONDER). Atlanta, GA: CDC; 2016.
dc.identifier.citedreferenceAnderson R. N., Rosenberg H. M. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 1998; 47: 1–16.
dc.identifier.citedreferenceFine J. P., Gray R. J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496 – 509.
dc.identifier.citedreferenceWhite I. R., Royston P., Wood A. M. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30: 377 – 399.
dc.identifier.citedreferenceBinswanger I. A., Whitley E., Haffey P. R., Mueller S. R., Min S. J. A patient navigation intervention for drug‐involved former prison inmates. Subst Abuse 2015; 36: 34 – 41.
dc.identifier.citedreferenceSpaulding A. C., Seals R. M., McCallum V. A., Perez S. D., Brzozowski A. K., Steenland N. K. Prisoner suvival inside and outside of the institution: implications for health‐care planning. Am J Epidemiol 2011; 173: 479 – 487.
dc.identifier.citedreferenceNagin D. S., Cullen F. T., Jonson C. L. Imprisonment and reoffending. Crime Justice 2009; 38: 115 – 200.
dc.identifier.citedreferenceDegenhardt L., Larney S., Kimber J., Gisev N., Farrell M., Dobbins T. et al. The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study. Addiction 2014; 109: 1306 – 1317.
dc.identifier.citedreferenceBird S. M., McAuley A., Perry S., Hunter C. Effectiveness of Scotland’s national naloxone programme for reducing opioid‐related deaths: a before (2006–10) versus after (2011–13) comparison. Addiction 2016; 111: 883 – 891.
dc.identifier.citedreferenceMarsden J., Stillwell G., Jones H., Cooper A., Eastwood B., Farrell M. et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction 2017; 112: 1408 – 1418.
dc.identifier.citedreferenceCenter for Substance Abuse Treatment. Substance Abuse Treatment for Adults in the Criminal Justice System; Treatment Issues Specific To Prisons. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005, pp. 187 – 210.
dc.identifier.citedreferenceWakeman S. E., McKinney M. E., Rich J. D. Filling the gap: the importance of Medicaid continuity for former inmates. J Gen Intern Med 2009; 24: 860 – 862.
dc.identifier.citedreferenceHarding D. J., Morenoff J. D., Wyse J. J. B. On the Outside: Prisoner Reentry and Reintegration. Chicago. IL: University of Chicago Press; 2019.
dc.identifier.citedreferenceTing A., Puisis M., Rodriguez S., Benson R., Mennella C., Davis F. Deaths in the Cook County jail: 10‐year report, 1995–2004. J Urban Health 2007; 84: 70 – 84.
dc.identifier.citedreferenceRudd R. A., Aleshire N., Zibbell J. E., Gladden R. M. Increases in drug and opioid overdose deaths—United States, 2000‐2014. Morb Mortal Wkly Rep 2016; 64: 1378 – 1382.
dc.identifier.citedreferenceSlavova S., O’Brien D. B., Creppage K., Dao D., Fondario A., Haile E. et al. Drug overdose deaths: let’s get specific. Public Health Rep 2015; 130: 339 – 342.
dc.identifier.citedreferenceRuhm C. J. Geographic variation in opioid and heroin involved drug poisoning mortality rates. Am J Prev Med 2017; 53: 745 – 753.
dc.identifier.citedreferenceLarney S., Burns L. Evaluating health outcomes of criminal justice populations using record linkage: the importance of aliases. Eval Rev 2011; 35: 118 – 128.
dc.identifier.citedreferenceHedegaard H., Miniño A. M., Warner M. Drug Overdose Deaths in the United States, 1999–2017. US Department of Health and Human Services NCS Data brief no. 329. Hyattsville, MD: Centers for Disease Control and Prevention; 2018.
dc.identifier.citedreferenceChandler R. K., Fletcher B. W., Volkow N. D. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA 2009; 301: 183 – 190.
dc.identifier.citedreferenceGreen T. C., Clarke J., Brinkley‐Rubinstein L., Marshall B. D. L., Alexander‐Scott N., Boss R. et al. Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatry 2018; 75: 405 – 407.
dc.identifier.citedreferenceAmerican Correctional Association, American Society of Addiction Medicine. Joint Public Correctional Policy on the Treatment of Opioid Use Disorders for Justice Involved Individuals. Alexandria, VA: American Correctional Association; 2018.
dc.identifier.citedreferenceNational Sheriffs Association and National Commission on Correctional Health Care. Jail‐based Medication Assisted Treatment: Promising Practices, Guidelines, and Resources for the Field. Alexandria, VA: National Sheriffs Association; 2018.
dc.identifier.citedreferenceNational Commission on Correctional Health Care. Standards for opioid treatment programs in correctional facilities. Chicago, IL: National Commission on Correctional Health Care; 2016.
dc.identifier.citedreferenceFinlay A. K., Harris A. H., Rosenthal J., Blue‐Howells J., Clark S., McGuire J. et al. Receipt of pharmacotherapy for opioid use disorder by justice‐involved U.S. veterans health administration patients. Drug Alcohol Depend 2016; 160: 222 – 226.
dc.identifier.citedreferenceBrinkley‐Rubinstein L., Cloud D. H., Davis C., Zaller N., Delany‐Brumsey A., Pope L. et al. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health 2017; 13: 25 – 31.
dc.identifier.citedreferenceWenger L. D., Showalter D., Lambdin B., Leiva D., Wheeler E., Davidson P. J. et al. Overdose education and naloxone distribution in the San Francisco County jail. J Correct Health Care 2019; 25: 394 – 404.
dc.identifier.citedreferenceKaeble D. Probation and Parole in the United States, 2016. Washington, DC: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2018.
dc.identifier.citedreferenceBronson J., Carson A. Prisoners in 2017. Washington, DC: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2019.
dc.identifier.citedreferenceWinkelman T. A., Chang V. W., Binswanger I. A. Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Netw Open 2018; 1: e180558.
dc.identifier.citedreferenceKaeble D., Cowhig M. Correctional populations in the United States, 2016. Washington, DC: US: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2018.
dc.identifier.citedreferenceBronson J., Stroop J., Zimmer S., Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009. Washington, DC: US: Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2018.
dc.identifier.citedreferenceBinswanger I. A., Blatchford P. J., Mueller S. R., Stern M. F. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med 2013; 159: 592 – 600.
dc.identifier.citedreferenceMerrall E. L., Kariminia A., Binswanger I. A., Hobbs M. S., Farrell M., Marsden J. et al. Meta‐analysis of drug‐related deaths soon after release from prison. Addiction 2010; 105: 1545 – 1554.
dc.identifier.citedreferenceRanapurwala S. I., Shanahan M. E., Alexandridis A. A., Proescholdbell S. K., Naumann R. B., Edwards D. Jr., et al. Opioid overdose mortality among former North Carolina inmates: 2000–2015. Am J Public Health 2018; 108: 1207 – 1213.
dc.identifier.citedreferenceBinswanger I. A., Stern M. F., Deyo R. A., Heagerty P. J., Cheadle A., Elmore J. G. et al. Release from prison—a high risk of death for former inmates. N Engl J Med 2007; 356: 157 – 165.
dc.identifier.citedreferenceForsyth S. J., Carroll M., Lennox N., Kinner S. A. Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study. Addiction 2018; 113: 937 – 945.
dc.identifier.citedreferenceBukten A., Staversuseth M. R., Skurtveit S., Tverdal A., Strang J., Clausen T. High risk of overdose death following release from prison: variations in mortality during a 15‐year observation period. Addiction 2017; 112: 1432 – 1439.
dc.identifier.citedreferenceCenter for Behavioral Health Statistics and Quality. Results from the 2017 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Center for Behavioral Health Statistics and Quality; 2018.
dc.identifier.citedreferenceBinswanger I. A., Maruschak L. M., Mueller S. R., Stern M. F., Kinner S. A. Principles to guide National Data Collection on the health of persons in the criminal justice system. Public Health Rep 2019; 134: 34S – 45S.
dc.identifier.citedreferenceBunting A. M., Oser C. B., Staton M., Eddens K. S., Knudsen H. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach. Addict Sci Clin Pract 2018; 13: 23.
dc.identifier.citedreferenceFriedmann P. D., Hoskinson R., Gordon M., Schwartz R., Kinlock T., Knight K. et al. Medication‐assisted treatment in criminal justice agencies affiliated with the criminal justice‐drug abuse treatment studies (CJ‐DATS): availability, barriers, and intentions. Subst Abuse 2012; 33: 9 – 18.
dc.identifier.citedreferenceHedrich D., Alves P., Farrell M., Stöver H., Møller L., Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 2011; 107: 501 – 517.
dc.identifier.citedreferenceMatusow H., Dickman S. L., Rich J. D., Fong C., Dumont D. M., Hardin C. et al. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat 2013; 44: 473 – 480.
dc.identifier.citedreferenceLipsey M. W., Cullen F. T. The effectiveness of correctional rehabilitation: a review of systematic reviews. Annu Rev Law Soc Sci 2007; 3: 297 – 320.
dc.identifier.citedreferenceAos S., Phipps P., Barnoski R., Lieb R. The Comparative Costs and Benefits of Programs to Reduce Crime, version 4.0. Olympia, WA: Washington State Institute for Public Policy; 2001.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.